Document is current
Any future updates will be listed below
-
Authors
Liu, Todd
McCormick, Patrick J.
Amar, David
Tan, Kay See
Lee, Jasme
Fischer, Gregory W.
Jackson, Laurel
Daghfal, David
Ramanathan, Lakshmi V.
Chen, Carol L.
Murtagh, Gillian
Blouin, Amanda G.
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
National Cancer Institute (P30CA008748)
- License Information
-
More Information
Article History
Received: 17 July 2025
Accepted: 3 November 2025
First Online: 30 December 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. The study was approved by the Institutional Review Board (IRB) of Memorial Sloan Kettering Cancer Center (approval IRB# 17–643). The need for informed consent from individual patients was waived by the IRB. Clinical trial number: not applicable.
: Not applicable.
: P.J.M.‘s spouse holds stock in Johnson & Johnson. G.M., D.D., and L.J. are full time employees of Abbott Laboratories.
